ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Down - Here's Why

Key Points

• ChronoScale shares dropped sharply, opening at $13.60 versus a prior close of $14.88 and last trading at $13.20 on volume of 61,246 shares.
• Analyst sentiment is mixed, resulting in a consensus “Hold” rating and an average price target of $19.00; Northland Securities issued an “Outperform” rating with a $32 target.
• The company reported a quarterly loss of $0.29 per share on $41.48 million in revenue, alongside a negative net margin of 135.66% and negative return on equity of 197.81%.

ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report)'s share price gapped down prior to trading on Thursday. The stock had previously closed at $14.88, but opened at $13.60. ChronoScale Corporation Common Stock shares last traded at $13.20, with a volume of 61,246 shares trading hands.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a "sell (d-)" rating to a "sell (d)" rating in a research report on Friday, October 9th. Northland Securities assumed coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an "outperform" rating and a $32.00 target price for the company. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $19.00.

ChronoScale Corporation Common Stock Stock Up 0.8%

The business has a fifty day moving average of $19.98 and a 200 day moving average of $18.15. The company has a market capitalization of $2.18 billion, a PE ratio of -2.79 and a beta of 0.98. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06.

ChronoScale Corporation Common Stock (NASDAQ:CHRN - Get Free Report) last released its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. The firm had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc lifted its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN - Free Report) by 104.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,338 shares of the company's stock after purchasing an additional 1,195 shares during the period. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent reporting period. Institutional investors own 6.42% of the company's stock.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.